The Aporia
Foreman, C. (2026, November 2). Fat jabs like Ozempic and Mounjaro more effective than diabetes drug metformin at preventing the disease - and patients have fewer side effects, major analysis finds. Daily Mail. https://www.dailymail.com/health/article-16258643/Fat-jabs-like-Ozempic-Mounjaro-effective-diabetes-drug-metformin-preventing-disease-patients-fewer-effects-major-analysis-finds.html?ns_mchannel=rss&ns_campaign=1490&ito=1490
Foreman, Ciaran. “Fat jabs like Ozempic and Mounjaro more effective than diabetes drug metformin at preventing the disease - and patients have fewer side effects, major analysis finds.” Daily Mail, 2 Nov. 2026, https://www.dailymail.com/health/article-16258643/Fat-jabs-like-Ozempic-Mounjaro-effective-diabetes-drug-metformin-preventing-disease-patients-fewer-effects-major-analysis-finds.html?ns_mchannel=rss&ns_campaign=1490&ito=1490.
Foreman, Ciaran. “Fat jabs like Ozempic and Mounjaro more effective than diabetes drug metformin at preventing the disease - and patients have fewer side effects, major analysis finds.” Daily Mail, November 2, 2026. https://www.dailymail.com/health/article-16258643/Fat-jabs-like-Ozempic-Mounjaro-effective-diabetes-drug-metformin-preventing-disease-patients-fewer-effects-major-analysis-finds.html?ns_mchannel=rss&ns_campaign=1490&ito=1490.
Dated from the outlet's own feed. Check the original for its byline.
A major analysis suggests that fat jabs like Ozempic and Mounjaro may be more effective at preventing type 2 diabetes compared to metformin, currently the gold standard treatment. The Mayo Clinic in Arizona's research found that patients on GLP-1 injections had a 31% lower risk of developing type 2 diabetes and were also less likely to suffer heart attacks, strokes, or heart failure. Additionally, these patients had a 41% lower risk of dying from any cause compared to those taking metformin. This could shift the use of GLP-1 medications to earlier stages for certain patients, potentially reversing prediabetes progression and reducing long-term health risks. The study highlights that one in 12 Britons are affected by prediabetes.